Alexandra Kropotova

Alexandra Kropotova

Chief Tech/Sci/R&D Officer at SAB BIOTHERAPEUTICS, INC.

Net worth: 719 $ as of 2024-04-29

51 year
Health Technology
Consumer Services

Profile

Alexandra Kropotova is an Independent Director at iBio, Inc. since 2020.
She is also the Chief Medical Officer & Executive Vice President at SAB Biotherapeutics, Inc. since 2022.
Previously, she worked as the Director & Head-Global Clinical Respiratory at Pfizer Inc. from 2002 to 2007.
From 2007 to 2016, she served as the Vice President-Strategy & Head-Strategic Planning at Sanofi SA. Dr. Kropotova then joined Teva Pharmaceuticals, Inc. as the VP-Global Specialty Research & Development from 2016 to 2022.
She holds an MBA from Ohio University Graduate College.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2023-10-24 418 ( 0.00% ) 719 $ 2024-04-29
2024-03-17 0 ( -.--% ) - $ 2024-04-29

Alexandra Kropotova active positions

CompaniesPositionStart
IBIO, INC. Director/Board Member 2020-10-13
SAB BIOTHERAPEUTICS, INC. Chief Tech/Sci/R&D Officer 2022-06-05
All active positions of Alexandra Kropotova

Former positions of Alexandra Kropotova

CompaniesPositionEnd
Corporate Officer/Principal 2022-05-31
Sanofi SA Corporate Officer/Principal 2015-12-31
PFIZER, INC. Director/Board Member 2006-12-31
See the detail of Alexandra Kropotova's experience

Training of Alexandra Kropotova

Ohio University Graduate College Masters Business Admin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Alexandra Kropotova's experience

Connections

100 +

1st degree connections

6

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies2
PFIZER, INC.

Health Technology

IBIO, INC.

Health Technology

Private companies3
Sanofi SA

Health Technology

SAB Biotherapeutics, Inc.

Health Technology

See company connections
  1. Stock Market
  2. Insiders
  3. Alexandra Kropotova